[
  {
    "objectID": "skills.html",
    "href": "skills.html",
    "title": "skills",
    "section": "",
    "text": "Omics\nProficient in sample preparation for whole exome seq, bulk RNA seq, single-cell RNA-seq, CITE-seq, and TCR/BCR-seq and its data analysis using R and Python.\nMicroscopy\nWell seasoned in brightfield, phase-contrast, fluorescence, confocal, and multiplex tissue imaging. Experienced in Transmission Electron Microscopy (TEM) and super-resolution microscopy.\nTissue Processing\nExpert in macro-dissection of tumour epithelium, preparation of FFPE blocks, tissue sectioning, haematoxylin and eosin staining (H&E), immunohistochemistry, micro-dissection of epithelial tissue for DNA isolation, and primary tumour-derived cell line generation.\n3D Cell Culture\nExperienced in generating spheroids and organoids, isolating and culturing immune cells, and establishing organoid‚Äìimmune cell co-culture systems.\n2D Cell Culture\nSkilled in the maintenance and manipulation of human cell lines, including drug treatment, cell viability assays, transfection, viral transduction, stable clone generation, immunofluorescence assays, migration and wound healing assays.\nMicroarray\nHands-on experience with array-based Comparative Genomic Hybridization (aCGH) and gene expression microarrays. Competent in R programming for data preprocessing, normalization, clustering, CMS, SAM, and GSEA. Skilled in using online tools and databases such as cBioPortal, Enrichr, UCSC Genome Browser (ENCODE), Gene Ontology, and WebGestalt.\nMolecular Biology\nProficient in DNA and RNA isolation from blood, frozen, and FFPE tissues; and in techniques like mutation screening, denaturing urea PAGE, formaldehyde agarose gel electrophoresis, reverse transcription, quantitative PCR (qPCR), molecular cloning, site-directed mutagenesis, chromatin immunoprecipitation (ChIP), and luciferase reporter assays.\nProtein Biology\nExperienced in protein extraction and purification, dialysis, SDS and native PAGE, and Western blotting for protein analysis.\nInfection Biology\nHands-on experience in culturing clinical isolates of Leishmania donovani, infecting human cell lines, and performing related assays including DNA fragmentation, Giemsa staining, CFSE and PI staining. Trained in Biosafety Level 2 (BSL-2) facility for SARS-CoV-2 diagnostics.\nModel Organisms\nExperienced in dissection and handling of BALB/cJ and C57BL/6J mice. Familiar with Drosophila melanogaster techniques through advanced training. Certified in ‚ÄúBasics of Mouse Genetics‚Äù and ‚ÄúIntroduction to CRISPR/Cas9 and Cre-lox Technologies‚Äù from The Jackson Laboratory, USA.\nBiostatistics and Epidemiology\nTrained in clinical study design, collection and analysis of clinicopathological and survival data, hypothesis testing, and data visualization."
  },
  {
    "objectID": "publications.html",
    "href": "publications.html",
    "title": "publications",
    "section": "",
    "text": "Sara A. George, Viswakalyan Kotapalli, Pandilla Ramaswamy, Raju Kumar, Swarnalata Gowrishankar, Shantveer G. Uppin, Murali D. Bashyam. Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma. Journal of Cellular Biochemistry, 2024;125:e30534.\n\n\nA.J. Caetano, Human Cell Atlas Oral and Craniofacial Bionetwork (Raju Kumar network member), I. Sequeira, and K.M. Byrd. A Roadmap for the Human Oral and Craniofacial Cell Atlas. Journal of Dental Research 2022, Vol. 101(11): 1274‚Äì1288.\n\n\nRaju Kumar, Viswakalyan Kotapalli, Ashmala Naz, Swarnalata Gowrishankar, Satish Rao, Jonathan R Pollack, and Murali Dharan Bashyam. XPNPEP3 is a novel transcriptional target of canonical Wnt/Œ≤-catenin signaling. Genes Chromosomes Cancer. 2018 Jun; 57(6):304‚Äì310.\n\n\nRaju Kumar, Ratheesh Raman, Viswakalyan Kotapalli, Swarnalata Gowrishankar, Saumyadipta Pyne, Jonathan R. Pollack, and Murali D. Bashyam. Ca2+/nuclear factor of activated T cells signaling is enriched in early-onset rectal tumors devoid of canonical Wnt activation. J Mol Med (Berl). 2018 Feb; 96(2):135‚Äì146.\n\n\nRaju Kumar and Murali D. Bashyam. Multiple oncogenic roles of nuclear Œ≤-catenin. J Biosci. 2017 Dec; 42(4):695‚Äì707.\n\n\nAbstracts\n\n\nHamish Miller, Patricia Garrido, Wenhao Li, Raju Kumar, Iris Gines, Nikolaos Nikolaou, Tom Potter, Ma√≠ra Bailey, Fredrik Karpe, Matthew Neville, M√°rta Korbonits, William Griffiths, Yuqin Wang, William Alazawi, Jeremy Tomlinson. THU-236-YI Oxysterol treatment causes indirect stellate cell activation: a potential mechanism linking steroid metabolising enzyme dysregulation with fibrosis. Journal of Hepatology (2024) 80(Suppl 1): S578.\n\n\nIris Gines Mir, Raju Kumar, Patricia Garrido, Wenhao Li, Hamish Miller, Hajar Saihi, Gillian Hood, William Alazawi. FRI-520 - B-cell activating factor in non-alcoholic steatohepatitis. Journal of Hepatology (2023) 78(Suppl 1): S825.\n\n\nRaju Kumar, Rana Ibrahim, Bassem Ben Cheikh, Emma Bailey, Hannah Cottom, Oliver Braubach, Trevor Graham, Jun Wang, Ines Sequeira. Abstract 5629: Spatial genomics and proteomics enable multimodal analyses of oral SCC clonal heterogeneity and interactions with tumor microenvironment. Cancer Res (2023) 83(7_Suppl): 5629.\n\n\nPreprint\n\n\nAna S Almeida, Tam T T Tran, Tarini S. Ghosh, Celine Ribiere, Cathriona Foley, Lisa A Azevedo, Paola Pellanda, Werner Frei, Cara M Hueston, Raju Kumar, Burkhardt Flemer, In√™s Sequeira, Micheal O‚ÄôRiordain, Fergus Shanahan, Paul W. O‚ÄôToole. Fiber-associated Lachnospiraceae reduce colon tumorigenesis by modulation of the tumor-immune microenvironment. bioRxiv (2021). doi: https://doi.org/10.1101/2021.02.24.432654.\n\n\nSequence submission\n\n\nCo-author in multiple SARS-CoV-2 viral genome submissions (submitted by Department of Biotechnology, Govt. of India) to the GISAID database. Accession ID: EPI_ISL_466839, EPI_ISL_466840, EPI_ISL_466841, EPI_ISL_466842, EPI_ISL_466843, EPI_ISL_466844. Contribution: RNA isolation."
  },
  {
    "objectID": "outreach-activities.html",
    "href": "outreach-activities.html",
    "title": "activities",
    "section": "",
    "text": "Training and mentoring students.\n\n\nPBL facilitator in MBBS Graduate Entry Program, Faculty of Medicine & Dentistry, Queen Mary University of London.\n\n\nServing as a member of the Blizard Postdoctoral Committee at the Blizard Institute, representing fellow postdoctoral researchers in institute meetings and contributing to initiatives that support postdoc development and engagement.\n\n\nSTEM Ambassador at the Centre of the Cell & Barts Metabolism Network, Queen Mary University of London. Engaged with school children through interactive sessions to foster curiosity in science and inspire future careers in STEM.\n\n\nGained training and research experience at the Centre for DNA Fingerprinting and Diagnostics (CDFD), India as part of the SARS-CoV-2 testing and sequencing initiative. Played a key role in establishing the RNA isolation facility and developed the standard operating procedure (SOP) for RNA extraction in alignment with guidelines from the World Health Organization (WHO) and the Indian Council of Medical Research (ICMR). Additionally, was responsible for training all initial volunteers involved in RNA isolation."
  },
  {
    "objectID": "fellowships-awards.html",
    "href": "fellowships-awards.html",
    "title": "fellowships & awards",
    "section": "",
    "text": "The Science and Engineering Research Board (SERB), Govt of India, financial assistance through International Travel Support (ITS) scheme to attend American Association of Cancer Research (AACR) Annual Meeting 2018, Chicago.\n\n\n\nImmunology Foundation bursary to attend American Association of Cancer Research (AACR) Annual Meeting 2018, Chicago.\n\n\n\nBest Poster Award at Research Colloquium of the Manipal Academy of Higher Education, Manipal held during 4-6 April 2016.\n\n\n\nQualified the Graduate Aptitude Test in Engineering (GATE) examination held in 2011 and 2012.\n\n\n\nQualified for Council of Scientific & Industrial Research (CSIR) - Junior research fellow (JRF) examination in CSIR/UGC NET examination held in June 2011.\n\n\n\nQualified for National Dairy Research Institute (NDRI) fellowship under Indian Council of Agricultural Research (IACR) examination held in 2010."
  },
  {
    "objectID": "blog/postdoc_pipettes_pages.html",
    "href": "blog/postdoc_pipettes_pages.html",
    "title": "Postdoc, Pipettes, and Pages: A New Chapter Begins",
    "section": "",
    "text": "Hello everyone!\nI am a postdoctoral researcher working at the intersection of immunology and metabolism, with a focus on T cell-mediated responses in Metabolic dysfunction-associated steatotic liver disease (MASLD). It is a niche but rapidly advancing field where immune-metabolic crosstalk is reshaping how we understand chronic diseases. My work explores how immune cells communicate across tissues like liver and adipose, uncovering pathways that drive inflammation and fibrosis in MASLD.\nMy scientific journey began in India, rooted in cancer biology, and has since led me to London, where I now investigate clinical immunology using human samples and multiomics technologies. Along the way, I have come to appreciate that science isn‚Äôt just about conducting experiments - It is also about communicating, questioning, and connecting.\nAs someone who bridges both wet-lab experiments and computational analysis, I constantly find myself shifting between minute technical decisions - like optimising antibody staining or choosing clustering parameters in Seurat - and broader conceptual questions about immune regulation and disease progression. That duality is exciting but also mentally taxing, and in the chaos of experiments and deadlines, I kept telling myself I had start this blog ‚Äúsoon.‚Äù\nTruth is, I have been procrastinating on writing this for a long time. Not because I didn‚Äôt want to - but because like many postdocs, I often felt too stretched, too unsure, or too perfectionistic to start. Between visa renewals, publication pressure, and the sheer unpredictability of working with human samples, finding time (and mental space) to write for myself felt like a luxury.\nBut I have come to realise that writing doesn‚Äôt have to wait for perfect clarity. In fact, this blog is an attempt to bring clarity through writing - A personal and professional space to document what I am learning, reflect on the messy parts of science, and share insights that might resonate with others walking a similar path.\n\n\n\nImage: My research depiction created using OpenAI tools\n\n\nHere, you can expect posts that touch on topics close to my work:\n\n\nT cells in tissue inflammation and fibrosis\n\n\nSingle-cell data analysis\n\n\nHuman immunopathology in the context of liver disease\n\n\nComputational tools I have found useful (and those I am still wrestling with)\n\n\nReflections on the postdoc experience, perspective of an international researcher\n\n\nThis space will not be just a summary of what I have figured out - It will be a living archive of things I didn‚Äôt even realise I knew until I had to explain them. If you are someone who lives between code and cell culture, between curiosity and imposter syndrome - welcome aboard.\nLet us explore science not only as a discipline but as a dialogue."
  },
  {
    "objectID": "about.html",
    "href": "about.html",
    "title": "about me",
    "section": "",
    "text": "I am a multidisciplinary researcher with expertise in both wet lab and computational techniques, working extensively in the processing and analysis of human clinical samples.\nI was born in a small village in Bihar, India. My research journey began during my bachelor‚Äôs studies at Anugrah Narayan College, Patna, where I formed lasting friendships and developed a keen interest in science. Together with friends, I embarked on Master‚Äôs degree in Animal Biotechnology at the University of Hyderabad. It was during this time, inspired by the cutting-edge genomics facility at the School of Life Sciences, that I developed a strong interest in genomics.\nTo pursue my interest, I did PhD from the Laboratory of Molecular Oncology at the Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad. My doctoral research focused on early-onset sporadic rectal cancer (EOSRC), where I developed a growing interest in organoids model and T cells mediated immunopathogenesis.\nFollowing my research at CDFD, I moved to Queen Mary University of London, where I followed my research interests and generated organoids from different regions of the mouse oral cavity and established Organoids ‚Äì T cell co-culture systems.\nCurrently at Barts Liver Centre, I am investigating the immunopathogenesis of Metabolic dysfunction-associated steatotic liver disease (MASLD). My research focuses on profiling the T cell and B cell repertoire and its functional responses in early-stage MASLD associated fibrosis.\nBeyond the lab, I am deeply committed to science communication and education, and I actively engage with students and broader communities to share knowledge and inspire curiosity in biomedical science."
  },
  {
    "objectID": "blog/liver.html",
    "href": "blog/liver.html",
    "title": "From Prometheus to P450: Why the Liver Deserves Our Attention",
    "section": "",
    "text": "Hello everyone!\nWelcome to my blog üéâ\nToday, I want to shift the focus slightly not away from science, but deeper into one of the organs at the heart of it all: the liver.\nThe liver is one of the most vital, complex, and fascinating organs in the human body. It processes everything we eat or drink, filters toxins, stores energy, regulates immunity, and can regenerate itself like no other organ. Despite all this, the liver often remains in the scientific and public shadow. But not always: ancient cultures recognised its power in ways modern medicine is only beginning to understand. This post explores the rich interplay of liver mythology, biology, and modern science: Prometheus‚Äôs eternal punishment to today‚Äôs fight against metabolic liver disease.\nThe Liver in Ancient Belief and Myth\n\nIn ancient Mesopotamia, around 2000 BCE, priests practiced hepatoscopy, a ritual of divination using the livers of sacrificed animals, most commonly sheep. They believed the liver held divine messages, and clay models, such as the Babylonian Liver Tablet from Nineveh, were used to train diviners in interpreting these sacred signs.\n\nAcross the Mediterranean, the liver played a symbolic role in Greek mythology. In the tales of Prometheus, as told by Hesiod and Aeschylus, the Titan was condemned by Zeus to have his liver eaten daily by an eagle, only for it to regenerate overnight, A myth that surprisingly mirrors the liver‚Äôs real regenerative abilities.\n\nIn Traditional Chinese Medicine, the liver is more than a physical organ; it governs the flow of Qi (vital energy), influences emotional well-being, particularly anger, and supports decision-making and spiritual balance.\n\nMeanwhile, in Ayurveda, the ancient medical system of India, the liver is linked with the Pitta dosha, which oversees digestion, metabolism, and transformation. Ayurvedic practitioners have long used herbs like Kutki and Kalmegh to promote liver health and restore balance.\n\nThese traditions, spanning continents and millennia, highlight how cultures across time intuitively recognized the liver‚Äôs central importance to life, healing, and even cosmic order.\nThe Biological Marvel of the Liver\n\nThe liver is often described as the body‚Äôs metabolic hub due to its central role in processing nutrients and maintaining biochemical homeostasis. After a meal, nutrients absorbed from the gut enter the liver through the portal vein. Here, the liver converts glucose into glycogen for short-term energy storage, synthesises vital proteins such as albumin and clotting factors, and plays a pivotal role in lipid metabolism (breaking down) and distributing fats or storing them as needed. It also regulates amino acid levels and produces cholesterol, which is essential for hormone synthesis and cell membranes.\n\nBeyond metabolism, the liver serves as the body‚Äôs primary detoxification organ. It breaks down potentially harmful substances including alcohol, environmental toxins, and many pharmaceutical drugs. This detoxification largely occurs through the cytochrome P450 enzyme system, which modifies lipophilic compounds to make them more water-soluble and easier to excrete. These chemical transformations are essential in preventing the accumulation of toxic substances in the body.\n\nAnother vital function of the liver is bile production. Bile is a greenish fluid that helps emulsify dietary fats in the small intestine, allowing for their digestion and absorption. It also aids in the absorption of fat-soluble vitamins like A, D, E, and K. Bile is stored in the gallbladder and released into the duodenum in response to food intake, especially fatty meals. This multifaceted role of the liver: As a metabolic processor, chemical purifier, and digestive partner, underlines its importance in nearly every aspect of human physiology.\n\nOne of the most remarkable features of the liver is its ability to regenerate. Unlike most organs, the liver can restore its original size and function even after substantial tissue loss up to 70% in some cases. This regenerative capacity is not simply about cell replacement but involves a finely tuned response of hepatocytes (the main liver cells), supported by non-parenchymal cells such as Kupffer cells, stellate cells, and endothelial cells. Following injury or partial removal (as in liver surgery or transplantation), a cascade of molecular signals,growth factors, cytokines, and metabolic cues-triggers the proliferation of existing liver cells rather than relying on stem cell populations. This regenerative process ensures the rapid restoration of liver mass and function while maintaining its complex architecture.\n\nThe myth of Prometheus, whose liver regrew daily after being devoured, turns out to echo a biological truth long before it was understood scientifically. This unique ability makes the liver not only resilient but also central to surgical and therapeutic approaches for liver disease.\n\nReflections: Why This Matters\nFrom divine organ to overlooked regulator, the liver deserves renewed attention. Its central role in metabolism, immunity, and chronic disease progression makes it not just a scientific challenge, but a public health priority. As someone from India now working in London on T cell-driven liver disease, I see this blog post as a bridge between ancient reverence and modern research, between regional need and global science.\n\nThe liver isn‚Äôt just about detox. It‚Äôs about balance, resilience, and transformation: whether in myth or in medicine"
  },
  {
    "objectID": "blog.html",
    "href": "blog.html",
    "title": "blog",
    "section": "",
    "text": "From Prometheus to P450: Why the Liver Deserves Our Attention\n\n\n\n\n\n\n\n\n\nMay 10, 2025\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPostdoc, Pipettes, and Pages: A New Chapter Begins\n\n\n\n\n\n\n\n\n\nApr 24, 2025\n\n\n\n\n\n\n\n\nNo matching items"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Raju Kumar",
    "section": "",
    "text": "I am an enterprising biomedical research scientist dedicated to dissect the role of T cells in disease outcomes. My current research focuses on understanding T cells involvement in the liver, adipose tissues, and blood of patients with early-stage liver fibrosis. Through this work, I aim to advance our understanding of the early-stage liver fibrosis drivers and contribute to the development of innovative therapeutic strategies."
  },
  {
    "objectID": "index.html#interests",
    "href": "index.html#interests",
    "title": "Raju Kumar",
    "section": "Interests",
    "text": "Interests\n\nT cells\nOrganoids\nSingle Cell Multi-Omics\n\nSpatial Transcriptomics & Proteomics\n\nAdaptive Immune Receptor Repertoire"
  },
  {
    "objectID": "index.html#education",
    "href": "index.html#education",
    "title": "Raju Kumar",
    "section": "Education",
    "text": "Education\nPhD in Molecular Oncology\nManipal Academy of Higher Education, India\nJuly 2012 ‚Äì Oct 2018\nM.Sc in Animal Biotechnology\nUniversity of Hyderabad, India\nAug 2010 ‚Äì July 2012\nB.Sc (Honours) in Biotechnology\nMagadh University, Bodhgaya, India\nAug 2007 ‚Äì June 2010"
  },
  {
    "objectID": "presentations.html",
    "href": "presentations.html",
    "title": "presentations",
    "section": "",
    "text": "European Association for the Study of the Liver (EASL) Congress 2025, Amsterdam held from 7-10 May 2025.\n\n\nMathematical and Statistical Aspects of Molecular Biology (MASAMB) 2024 conference, London held from 29-30 August 2024.\n\n\n\nBritish Association for the Study of the Liver (BASL) Science Retreat 2024, London held from 19-21 August 2024.\n\n\n\nAmerican Association of Cancer Research (AACR) Annual Meeting 2018, Chicago held from 14-18 April 2018.\n\n\n\n37th Indian Association of Cancer Research (IACR) annual convention 2018, Kolkata held from 23-25 February 2018.\n\n\n\nInternational Congress of Cell Biology 2018, Hyderabad held from 27-31 January 2018.\n\n\n\nResearch Colloquium of the Manipal Academy of Higher Education, Manipal held from 4-6 April 2016.\n\n\n\n822d Annual Meeting of Society of Biological Chemists, India, and International Conference on Genomes: Mechanism and Function, Hyderabad held from 2-5 December 2013."
  },
  {
    "objectID": "research-experience.html",
    "href": "research-experience.html",
    "title": "research experience",
    "section": "",
    "text": "Postdoctoral Researcher\nQueen Mary University of London, UK\nNovember 2022 ‚Äì Present\nI am currently investigating the immunopathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), with a focus on understanding the mechanistic links between innate and adaptive immune cells across anatomical compartments. In this project, we employ a multi-omics approach integrating CITE-seq and TCR/BCR-seq on CD45‚Å∫ immune cells isolated from simultaneously collected liver, peripheral blood, subcutaneous, and visceral adipose tissues obtained during bariatric surgery. Furthermore, I perform high-dimensional spatial profiling using multiplex immunostaining (Cell DIVE‚Ñ¢) on the same tissue specimens subjected to CITE-seq, enabling spatial validation and contextualisation of the single-cell transcriptomic data.\nPostdoctoral Researcher\nQueen Mary University of London, UK\nNovember 2020 ‚Äì November 2022\nIn this role, I investigated the functional and spatial intra-tumour heterogeneity in oral squamous cell carcinoma (OSCC), focusing on tumour‚Äìimmune interactions that drive epithelial-to-mesenchymal transition (EMT) and tumour progression. We performed exome sequencing and deep immune phenotyping of early-stage lesions, invasive OSCC, and nodal metastases. In parallel, I established organoids from distinct anatomical regions of the mouse oral cavity and developed organoids-T cell co-culture models to study epithelial-immune cell interactions involving CD4‚Å∫ and CD8‚Å∫ T cells.\nPostdoctoral Researcher\nCentre for DNA Fingerprinting and Diagnostics (CDFD), India\nOctober 2018 ‚Äì November 2020\nI collaborated with pathologists to profile the immune landscape of rectal cancer through histological techniques including H&E staining, immunohistochemistry, and image analysis. In parallel, I contributed to characterising the gene fusion landscape in colorectal cancer by performing in silico functional analyses using bioinformatics tools. Shortlisted fusion candidates were subsequently validated through PCR amplification, Sanger sequencing, cloning, and in vitro functional assays.\nAdditionally, my research focused on elucidating the regulatory role of ARID1B, a component of the SWI/SNF chromatin-remodelling complex, in transcriptional control via enhancer‚Äìpromoter looping. I employed ARID1B pull-down assays followed by mass spectrometry to identify interacting partners, and validated key enhancer‚Äìpromoter interactions using ChIP-qPCR and ChIP-loop techniques.\nDoctoral Researcher\nCentre for DNA Fingerprinting and Diagnostics (CDFD), India\nJuly 2012 ‚Äì October 2018\nMy Ph.D.¬†research focused on characterising unique molecular subtypes of early-onset sporadic rectal cancer (EOSRC), particularly cases lacking canonical Wnt/Œ≤-catenin pathway activation, which is prevalent in over half of Indian patients with EOSRC. Using gene expression microarrays, I compared Wnt-negative and Wnt-positive tumours and identified: (a) Enrichment of Ca¬≤‚Å∫/NFAT signalling in Wnt-negative tumours (b) An eight-gene transcriptional signature distinguishing Wnt-positive from Wnt-negative tumours (c) XPNPEP3 as a novel transcriptional target of the Wnt/Œ≤-catenin pathway.\nMaster‚Äôs Research Project\nUniversity of Hyderabad, India\nAugust 2010 ‚Äì July 2012\nI conducted a one-year dissertation project on the mechanisms of drug resistance in Leishmania donovani, focusing on Amphotericin B resistance in the amastigote stage. I identified differential isoform expression of S-Adenosyl-L-Methionine: C-24-Œî-Sterol Methyltransferase (SCMT) between wild-type and resistant strains.\nUndergraduate Research Training\nMagadh University, India\nAugust 2007 ‚Äì June 2010\nDuring my bachelor‚Äôs studies, I undertook summer research training each year:\n2010 ‚Äì Cancer Biology, Mahavir Cancer Institute & Research Centre, India.\nGained hands-on experience in preparing FFPE blocks, H&E staining, and microscopic evaluation of histopathological sections.\n2009 ‚Äì Immunological Techniques, Path Laboratory, India.\nTrained in blood separation, lymphocyte and PMN isolation, agglutination assays, and blood group typing.\n2008 ‚Äì Clinical Pathology, Patna Medical College and Hospital, India.\nLearned differential blood cell identification and various biochemical assays, including CRP, ESR, glucose, and hormone level assessments."
  }
]